Bliss GVS Pharma Limited (BLISSGVS) Share Price & AI Investment Analysis

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India. Track Bliss GVS Pharma Limited's live NSE:BLISSGVS share price ₹694.60 (+5.08%), market cap ₹₹74B, P/E 55.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for BLISSGVS — real-time NSE India stock intelligence.